Euro Canals News

Your most trusted news channel


While scientists and doctors are in the early stages of investigating Paxlovid rebound, early reports indicate rebound tends to be mild. Symptoms that return are commonly sniffles, sore throat or a cough.

There are very few reports of severe rebound cases requiring hospitalisation and no reports on rebound resulting in death that I’m aware of.

It’s important to remember that if you still have symptoms you might still be infectious. Guidelines across Australia make it clear if you have ongoing symptoms after your isolation period, you need to take care not to spread the virus.

However, a person in rebound – even if they’re symptom-free – might also be able to spread the virus.

So is Paxlovid doing what we need?

If your goal is to prevent severe disease, hospitalisation and death in high-risk people, then Paxlovid is doing a great job.

However, if you want to shorten the duration of your symptoms, maybe Paxlovid isn’t the wonder drug we hoped for.

Lara Herrero is a research leader in Virology and Infectious Disease at Griffith University. This commentary first appeared in The Conversation.